{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:59:30Z","timestamp":1782489570807,"version":"3.54.5"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p><jats:bold>Background and Aims:<\/jats:bold> The N-terminal pro-B-type natriuretic peptide (NT-proBNP) may predict adverse cardiovascular outcomes in patients with diabetes. However, its prognostic value in patients with multivessel disease (MVD) undergoing coronary revascularization remains unclear. This study aimed to evaluate the prognostic significance of preprocedural NT-proBNP levels in diabetic patients with MVD undergoing coronary revascularization.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A total of 886 consecutive diabetic patients with MVD who underwent coronary revascularization were enrolled in this study. Patients were divided into quartiles according to their pre-procedural NT-proBNP levels. Kaplan-Meier curves and Cox regression analyses were performed to evaluate the risk of cardiovascular events, including all-cause death, cardiovascular death, myocardial infarction (MI), stroke, and major adverse cardiovascular events (MACE), according to the NT-proBNP quartiles.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> During a median follow-up period of 4.2 years, 111 patients died (with 82 being caused by cardiovascular disease), 133 had MI, 55 suffered from stroke, and 250 experienced MACE. Kaplan-Meier curves demonstrated that NT-proBNP levels were significantly associated with higher incidences of all-cause death, cardiovascular death, MI, and MACE (log-rank test, <jats:italic>P<\/jats:italic> &amp;lt; 0.001, respectively). Multivariate Cox regression analysis revealed that NT-proBNP level was an independent predictor of adverse outcomes, including all-cause death (HR, 1.968; 95% CI, 1.377\u20132.812; <jats:italic>P<\/jats:italic> &amp;lt; 0.001), cardiovascular death (HR, 1.940; 95% CI, 1.278\u20132.945; <jats:italic>P<\/jats:italic> = 0.002), MI (HR, 1.722; 95% CI, 1.247\u20132.380; <jats:italic>P<\/jats:italic> = 0.001), and MACE (HR, 1.356; 95% CI, 1.066\u20131.725; <jats:italic>P<\/jats:italic> = 0.013). The role of NT-proBNP in predicting adverse outcomes was similar in patients with stable angina pectoris and acute coronary syndrome. Moreover, preprocedural NT-proBNP alone discriminated against the SYNTAX II score for predicting all-cause death [area under the curve (AUC), 0.662 vs. 0.626, <jats:italic>P<\/jats:italic> = 0.269], cardiovascular death (AUC, 0.680 vs. 0.622, <jats:italic>P<\/jats:italic> = 0.130), MI (AUC, 0.641 vs. 0.579, <jats:italic>P<\/jats:italic> = 0.050), and MACE (AUC, 0.593 vs. 0.559, <jats:italic>P<\/jats:italic> = 0.171). The addition of NT-proBNP to the SYNTAX II score showed a significant net reclassification improvement, integrated discrimination improvement, and improved C-statistic (all <jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> NT-proBNP levels were an independent prognostic marker for adverse outcomes in diabetic patients with MVD undergoing coronary revascularization, suggesting that preprocedural NT-proBNP measurement might help in the risk stratification of high-risk patients.<\/jats:p>","DOI":"10.3389\/fcvm.2021.721260","type":"journal-article","created":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T21:04:12Z","timestamp":1633554252000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic Significance of Preprocedural N-Terminal Pro-B-Type Natriuretic Peptide Assessment in Diabetic Patients With Multivessel Coronary Disease Undergoing Revascularization"],"prefix":"10.3389","volume":"8","author":[{"given":"Le","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-liang","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-bin","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.jacc.2005.12.058","article-title":"Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound","volume":"47","author":"Nicholls","year":"2006","journal-title":"J Am Coll Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS) developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the medicine, angioplasty, or surgery study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation."},{"key":"B4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.athoracsur.2006.08.050","article-title":"Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease","volume":"83","author":"Hueb","year":"2007","journal-title":"Ann Thorac Surg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.jacc.2011.02.074","article-title":"Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the international multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease","volume":"58","author":"Min","year":"2011","journal-title":"J Am Coll Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis treatment of acute chronic heart failure: the task force for the diagnosis treatment of acute chronic heart failure of the European society of cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1177\/1741826711420015","article-title":"A comparison of NT-proBNP and albuminuria for predicting cardiac events in patients with diabetes mellitus","volume":"19","author":"Clodi","year":"2012","journal-title":"Eur J Prev Cardiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ejhf.1359","article-title":"The prognostic value of troponin T and N-terminal pro B-type natriuretic peptide, alone and in combination, in heart failure patients with and without diabetes","volume":"21","author":"Rorth","year":"2019","journal-title":"Eur J Heart Fail."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e017462","DOI":"10.1161\/JAHA.120.017462","article-title":"NT-proBNP by itself predicts death and cardiovascular events in high-risk patients with type 2 diabetes mellitus","volume":"9","author":"Malachias","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.2337\/dc18-0109","article-title":"Serial measurement of natriuretic peptides and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE trial","volume":"41","author":"Jarolim","year":"2018","journal-title":"Diabetes Care."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e004743","DOI":"10.1161\/JAHA.116.004743","article-title":"Role of B-type natriuretic peptide and n-terminal prohormone BNP as predictors of cardiovascular morbidity and mortality in patients with a recent coronary event and type 2 diabetes mellitus","volume":"6","author":"Wolsk","year":"2017","journal-title":"J Am Heart Assoc."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.amjcard.2020.01.025","article-title":"N-terminal Pro B-type natriuretic peptide and high-sensitivity cardiac troponin as markers for heart failure and cardiovascular disease risks according to glucose status (from the Multi-Ethnic Study of Atherosclerosis [MESA])","volume":"125","author":"Nguyen","year":"2020","journal-title":"Am J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.2337\/dc15-1760","article-title":"Natriuretic peptide and high-sensitivity troponin for cardiovascular risk prediction in diabetes: the atherosclerosis risk in communities (ARIC) study","volume":"39","author":"Gori","year":"2016","journal-title":"Diabetes Care."},{"key":"B14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/jamacardio.2016.3030","article-title":"Prognostic implications of biomarker assessments in patients with type 2 diabetes at high cardiovascular risk: a secondary analysis of a randomized clinical trial","volume":"1","author":"Scirica","year":"2016","journal-title":"JAMA Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s00125-004-1607-0","article-title":"Plasma N-terminal pro-brain natriuretic peptide as a major risk marker for cardiovascular disease in patients with type 2 diabetes and microalbuminuria","volume":"48","author":"Gaede","year":"2005","journal-title":"Diabetologia."},{"key":"B16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12933-021-01271-0","article-title":"Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study","volume":"20","author":"Liu","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-021-01221-w","article-title":"Performance of the recommended ESC\/EASD cardiovascular risk stratification model in comparison to SCORE and NT-proBNP as a single biomarker for risk prediction in type 2 diabetes mellitus","volume":"20","author":"Prausmuller","year":"2021","journal-title":"Cardiovasc Diabetol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e012797","DOI":"10.1161\/JAHA.119.012797","article-title":"Clinical and biomarker predictors of expanded heart failure outcomes in patients with type 2 diabetes mellitus after a recent acute coronary syndrome: insights from the EXAMINE trial","volume":"9","author":"Sharma","year":"2020","journal-title":"J Am Heart Assoc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the reduction of atherothrombosis for continued health (REACH) registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation."},{"key":"B21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11606-015-3556-3","article-title":"Diabetes and prior coronary heart disease are not necessarily risk equivalent for future coronary heart disease events","volume":"31","author":"Rana","year":"2016","journal-title":"J Gen Intern Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2337\/dc19-0274","article-title":"Lipoprotein(a) and cardiovascular outcomes in patients with coronary artery disease and prediabetes or diabetes","volume":"42","author":"Jin","year":"2019","journal-title":"Diabetes Care."},{"key":"B23","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-019-0936-8","article-title":"Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status","volume":"18","author":"Jin","year":"2019","journal-title":"Cardiovasc Diabetol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1042\/CS20120336","article-title":"Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease","volume":"124","author":"Ndrepepa","year":"2013","journal-title":"Clin Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","article-title":"Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II","volume":"381","author":"Farooq","year":"2013","journal-title":"Lancet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1093\/eurheartj\/ehx138","article-title":"Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials","volume":"38","author":"Cavalcante","year":"2017","journal-title":"Eur Heart J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.metabol.2016.06.002","article-title":"Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: the cardiovascular health study","volume":"65","author":"Brutsaert","year":"2016","journal-title":"Metabolism."},{"key":"B28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1373\/clinchem.2012.194167","article-title":"Prospective evaluation of B-type natriuretic peptide concentrations and the risk of type 2 diabetes in women","volume":"59","author":"Everett","year":"2013","journal-title":"Clin Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.2337\/dc20-0553","article-title":"Opposing associations of NT-proBNP with risks of diabetes and diabetes-related complications","volume":"43","author":"Birukov","year":"2020","journal-title":"Diabetes Care."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.1093\/eurheartj\/ehz394","article-title":"Implications of N-terminal pro-B-type natriuretic peptide in patients with three-vessel disease","volume":"40","author":"Zhang","year":"2019","journal-title":"Eur Heart J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"859","DOI":"10.3967\/bes2018.117","article-title":"Prognostic value of NT-proBNP in stable coronary artery disease in chinese patients after percutaneous coronary intervention in the drug-eluting stent era","volume":"31","author":"Zhao","year":"2018","journal-title":"Biomed Environ Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1001\/jama.297.2.169","article-title":"N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease","volume":"297","author":"Bibbins-Domingo","year":"2007","journal-title":"JAMA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jacc.2004.07.057","article-title":"Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia","volume":"44","author":"Sabatine","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ahj.2020.12.017","article-title":"NT-proBNP level before primary PCI and risk of poor myocardial reperfusion: insight from the On-TIME II trial","volume":"233","author":"Fabris","year":"2021","journal-title":"Am Heart J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.jacc.2018.02.071","article-title":"B-type natriuretic peptide levels and mortality in patients with and without heart failure","volume":"71","author":"York","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1016\/j.jacc.2017.10.044","article-title":"Association of elevated NT-proBNP with myocardial fibrosis in the multi-ethnic study of atherosclerosis (MESA)","volume":"70","author":"Liu","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"107883","DOI":"10.1016\/j.jdiacomp.2021.107883","article-title":"Serum copeptin and NT-proBNP is associated with central aortic stiffness and flow hemodynamics in adolescents with type 1 diabetes: a pilot study","volume":"35","author":"Melena","year":"2021","journal-title":"J Diabetes Complications."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.721260\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T21:04:15Z","timestamp":1633554255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.721260\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":37,"alternative-id":["10.3389\/fcvm.2021.721260"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.721260","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"article-number":"721260"}}